Adding methotrexate to adalimumab does not improve treatment effectiveness or durability in adults with plaque psoriasis, according to a study. 1 Findings suggest that adalimumab monotherapy ...

Study: ENT-1-Targeted Polymersomes to Enhance the Efficacy of Methotrexate in Choriocarcinoma Treatment. Image Credit: Shutterstock AI Generator / Shutterstock.com In a recent study published in ...

Outcomes in methotrexate-induced kidney injury have shown improvement through treatment with the enzyme glucarpidase.

The FDA has expanded the approval of an oral liquid methotrexate solution to include children and adolescents with polyarticular juvenile idiopathic arthritis and acute lymphoblastic leukemia ...

The approval makes methotrexate, currently, the only only oral liquid methotrexate on the market approved for both adult and pediatric indications.

On March 26, 2024, the Federal Court dismissed Medexus and Medac’s action for patent infringement of Canadian Patent No 2,659,662 (the 662 Patent), ...

Jylamvo, a Food and Drug Administration (FDA)-approved oral solution formulation of methotrexate, is now available from Shorla Oncology and Eversana. Jylamvo is approved for the following indications: ...

Jylamvo contains 2mg of methotrexate per mL and is packaged in bottles containing 60mL of oral solution.

Jylamvo contains 2 mg of methotrexate per mL and is packaged in bottles containing 60 mL of oral solution. Each pack contains 1 bottle and a dosing syringe to ensure proper dosing.